Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study - Top-Institutions - MDSpire

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study

  • By

  • Rongrong Dai

  • Qianhui Hua

  • Xinyu Liu

  • Lanxin Ma

  • Ruijing Bao

  • Huijun Lei

  • Pengfei Yu

  • Yuting Liao

  • Juan Yang

  • Su Han

  • Jianmin Jiang

  • Hangjie Zhang

  • April 30, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    The University of Hong Kong
    The University of Hong Kong

    Hong Kong, N/A

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Vaccine Research
  • #2

    Chinese Center for Disease Control and Prevention (China CDC)
    Chinese Center for Disease Control and Prevention (China CDC)

    Beijing, N/A

    Key Differentiators

    • Epidemiology
    • Vaccine Safety
    • Public Health
  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Geriatrics
  • #4

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Vaccine Research
    • Infectious Diseases
  • #5

    Peking University Health Science Center
    Peking University Health Science Center

    Beijing, N/A

    Key Differentiators

    • Infectious Diseases
    • Immunology
    • Geriatrics

Original Source(s)

Related Content